Clinical & Pharma

Could Humans Soon Regrow Their Own Teeth?
Clinical & Pharma Could Humans Soon Regrow Their Own Teeth?

The loss of an adult tooth has long been considered a permanent event, a problem addressed only by synthetic replacements like dentures or implants that, while functional, are not a true biological restoration. However, a revolutionary wave of research emerging from Japan is challenging this

CDC Finds Drug-Resistant E. coli Is a Top Sepsis Threat
Clinical & Pharma CDC Finds Drug-Resistant E. coli Is a Top Sepsis Threat

A recent comprehensive investigation by the Centers for Disease Control and Prevention (CDC) has brought a critical public health challenge into sharp focus, identifying extraintestinal invasive Escherichia coli as the foremost cause of sepsis that begins outside of a hospital setting. This

Can US Biomedical Research Recover From a Year of Chaos?
Clinical & Pharma Can US Biomedical Research Recover From a Year of Chaos?

The American biomedical research landscape has emerged into 2026 bearing the deep and complex scars of a profoundly turbulent year, navigating a delicate balance between a renewed sense of financial security and a pervasive anxiety over the integrity of its foundational institutions. Following a

BioMarin Previews Lower Q4 Earnings Despite Sales Growth
Clinical & Pharma BioMarin Previews Lower Q4 Earnings Despite Sales Growth

BioMarin Pharmaceutical is currently navigating a complex financial landscape as it prepares to release its financial results for the fourth quarter of 2025, presenting a puzzling scenario for the investment community. The prevailing consensus suggests a significant year-over-year decline in the

Texas A&M Spotlights Future of Interdisciplinary Science
Clinical & Pharma Texas A&M Spotlights Future of Interdisciplinary Science

The complex health crises facing modern society, from pandemics to chronic diseases, increasingly demand solutions that transcend the traditional boundaries of scientific disciplines. Recognizing this critical shift, Texas A&M University recently convened the Life Sciences Graduate Recruitment

Closing the Diversity Gap in Parkinson's Research
Clinical & Pharma Closing the Diversity Gap in Parkinson's Research

The global map of Parkinson's disease is rapidly being redrawn, yet the landscape of the research dedicated to conquering it remains stubbornly fixed. A profound and widening disparity now exists between the populations most affected by this neurodegenerative condition and the focus of scientific

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later